Cerus (CERS) EBT Margin Growth (1y) (2011 - 2026)
Cerus (CERS) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | -287.00 |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | 772.00 |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | -464.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 233.00 |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn | 1,478.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,478.00 |
| Dec 31, 2025 | 186.00 |
| Sep 30, 2025 | 41,149.00 |
| Jun 30, 2025 | -101,152.00 |
| Mar 31, 2025 | 739.00 |
| Dec 31, 2024 | -270.00 |
| Sep 30, 2024 | 370,822.00 |
| Jun 30, 2024 | 1,469.00 |
| Mar 31, 2024 | 8,589.00 |
| Dec 31, 2023 | 684.00 |
| Sep 30, 2023 | -399,402.00 |
| Jun 30, 2023 | -1,377.00 |
| Mar 31, 2023 | -2,847.00 |
| Dec 31, 2022 | 36.00 |
| Sep 30, 2022 | 8,226.00 |
| Jun 30, 2022 | 8,406.00 |
| Mar 31, 2022 | 9,715.00 |
| Dec 31, 2021 | 919.00 |
| Sep 30, 2021 | 208,087.00 |
| Jun 30, 2021 | -198.00 |